Oxford-Based Brainomix Joins Elite Future Fifty Scale-Up Cohort

The Future Fifty, delivered by Tech Nation and the Founders Forum Group, acts as a launchpad for companies with significant growth trajectories. Its track record is substantial, having supported the development of nearly one-third of all UK tech unicorns. Brainomix joins a cohort of 25 companies spanning sectors from fintech to advanced manufacturing, which have collectively raised £1.47 billion. Carolyn Dawson OBE, CEO of Founders Forum Group, noted that the programme provides these founders with the global exposure and industry connections required to compete on an international stage.

For Brainomix, the recognition follows a period of rapid expansion. The company has already secured £49 million in funding and achieved over 30 regulatory clearances, including FDA and CE marks, for its imaging platforms. Its technology is currently deployed in more than 20 countries, where it assists clinicians in extracting precise data from medical images to guide urgent treatment decisions. Dr. Michalis Papadakis, CEO and co-founder, stated that the network provides a vital environment for the company to accelerate its ambitions as it works to establish its AI-powered solutions as a global clinical standard.